Immunomodulatory proteins with tunable affinities
US11319359B2 · kind B2 · utility
6Cited by
121References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 15, 2016 |
| Grant date | May 3, 2022 |
| Priority date | — |
| Expiry date | Nov 21, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Provided are immunomodulatory proteins and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.